首页 › 基金 › DV EQUITIES, LLC › AVTX

DV EQUITIES, LLC 对 AVTX 的持仓历史

AVALO THERAPEUTICS INC · 医疗保健

DV EQUITIES, LLC 在 Q2 2026 的 13F 申报中披露持有 AVTX(AVALO THERAPEUTICS INC)332,213 股,市值约 US$6.1M,约占其申报组合的 0.89%,在其申报持仓中市值排名第 26 位。 DV EQUITIES, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)332.21K 股
申报持仓市值$6.14M
组合权重0.89%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

DV EQUITIES, LLC 对 AVTX 的持仓演变

DV EQUITIES, LLC 于 Q2 2026 首次披露 AVTX 持仓:332,213 股(约 US$6.1M)。

逐季持仓明细

季度股数金额变化
Q2 2026 332.21K $6.14M 新进

关于 AVTX 与 13F 数据

AVTX(AVALO THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 83 只申报持有 AVTX,申报仓位最大的包括:Deep Track Capital, LP (US$66.7M), Caligan Partners LP (US$58.5M), TCG Crossover Management, LLC (US$55.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 AVTX 的基金

查看 AVTX 的全部基金持有人 →

常见问题

How long has DV EQUITIES, LLC held AVTX?

DV EQUITIES, LLC has disclosed AVTX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is DV EQUITIES, LLC's current position in AVTX?

As of Q2 2026, DV EQUITIES, LLC holds 332.21K shares of AVTX (AVALO THERAPEUTICS INC), valued at $6.14M, representing 0.89% of its reported portfolio and ranking #26.

Has DV EQUITIES, LLC been buying or selling AVTX?

In the latest 13F filing (Q2 2026), DV EQUITIES, LLC newly opened its position in AVTX.

Which other funds hold AVTX?

Other major institutional holders of AVTX include Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC, among 83 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.